WFA
TNDM icon

Wipfli Financial Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Wipfli Financial Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$62K Buy
+1,291
New +$70.8K ﹤0.01% 973

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wipfli Financial Advisors's TNDM Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Tandem Diabetes Care (TNDM) in Q3 2022: 1,291 shares worth $62K. The stake represents ﹤0.01% of the portfolio and ranks #973 among its holdings.

299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Wipfli Financial Advisors held 1,291 shares of Tandem Diabetes Care worth $62K as of Q3 2022.
  • Tandem Diabetes Care was a new Wipfli Financial Advisors position in Q3 2022.
  • Tandem Diabetes Care made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #973 holding.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.